| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 4 |
| 1 | FLUOROURACIL | 4 |
| 2 | OXALIPLATIN | 4 |
| 3 | FLUOROURACIL CREAM, 0.5% | 3 |
| 4 | LEVOLEUCOVORIN | 3 |
| 5 | LEVOLEUCOVORIN CALCIUM | 3 |
| 6 | LEVOLEUCOVORIN INJECTION | 3 |
| 7 | ZOLBETUXIMAB | 3 |
| 8 | OCTREOTIDE | 2 |
| 9 | OCTREOTIDE ACETATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZOLBETUXIMAB | 3 | 0.0020 |
| 1 | LEVOLEUCOVORIN INJECTION | 3 | 0.0010 |
| 2 | LEVOLEUCOVORIN | 3 | 0.0008 |
| 3 | TOPOTECAN | 1 | 0.0002 |
| 4 | REGORAFENIB | 1 | 0.0001 |
| 5 | OCTREOTIDE ACETATE | 2 | 0.0001 |
| 6 | OXALIPLATIN | 4 | 0.0001 |
| 7 | FLUOROURACIL | 4 | 0.0001 |
| 8 | EXEMESTANE | 1 | 0.0000 |
| 9 | CAPECITABINE | 4 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 1 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 2 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 3 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 7 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 2 | 0.0000 |